The National Institute on Drug Abuse describes addiction as a “disorder characterized by compulsive drug seeking and use despite adverse consequences.” The addictive substance might be an illegal drug, a prescription drug, or inhalant. Tolerance for the substance leads to an increase in use over time. Addictions also include behaviors like pornography, gambling, or sexual compulsions.
Daytryp provides highly effective and medically proven psychedelic treatment options for people suffering from addiction and substance abuse. Our methods are beneficial especially for those who have tried traditional treatments without success. We provide each client with the resources necessary to make transformative and lasting changes.
This powerful healing journey happens under the medical supervision of a supportive and knowledgeable team. Our mission is to help you unlock your potential by interrupting the harmful pattern of addiction via psychedelic therapies and replacing it with new and healthy perceptions.
At Daytryp Health, we view addiction as part of the larger issue of the current mental health epidemic in America. Out of the 21 million Americans struggling with addiction, approximately 8.5 million suffer from both a mental health issue and a substance use disorder. We understand that often people turn to substances to escape their problems, not because there is something wrong with them. We offer a breakthrough treatment for substance abuse and addiction via Ketamine Assisted Psychotherapy. Click below to learn more.
3,4-methylenedioxy-methamphetamine (MDMA) therapy is an upcoming, highly effective and innovative treatment approach for those suffering from post-traumatic stress disorder (PTSD) and other mental health conditions. It combines the psychoactive compound MDMA with guided psychological support, and has shown as much as a 75% success rate in patients suffering from PTSD, setting an unprecedented standard for treatment. MDMA therapy is not currently available, but expected to gain FDA approval later this year.